Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3442 Target Snapshot

Glutamate receptor ionotropic, NMDA 2B · SINGLE PROTEIN · Mus musculus

94Compounds
12Assays
1Approved Drugs
79.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q01097. Use UniProt Q01097 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q01097 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Glutamate receptor ionotropic, NMDA 2B as ChEMBL target CHEMBL3442, mapped to UniProt Q01097. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Glutamate receptor ionotropic, NMDA 2B
SINGLE PROTEIN · Mus musculus
As of 2026-09-13
ChEMBL target ID
CHEMBL3442
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q01097
Glutamate receptor ionotropic, NMDA 2B
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Glutamate receptor ionotropic, NMDA 2B is the right protein anchor across sources, using UniProt Q01097 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGlutamate receptor ionotropic, NMDA 2B
UniProt AccessionQ01097
Component TypeProtein
Sequence Length1482 aa

Glutamate receptor ionotropic, NMDA 2B

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Glutamate receptor ionotropic, NMDA 2B, mapped to UniProt Q01097. Sequence length is 1482 aa.

Mapped IDQ01097
Review nameGlutamate receptor ionotropic, NMDA 2B
OrganismMus musculus
Clinical Profile

Clinical Phase Distribution

1
Approved
1
Phase II
Assay Mix

Activity Type Distribution

IC5054.0
KI25.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL282433 9.22 Ki 0.6 Preclinical
CHEMBL4086848 9.2 IC50 0.631 Preclinical
CHEMBL4094573 9.2 IC50 0.631 Preclinical
CHEMBL493054 9.1 Ki 0.8 Preclinical
CHEMBL4078903 9.0 IC50 1.0 Preclinical
CHEMBL4095807 9.0 IC50 1.0 Preclinical
CHEMBL4526884 9.0 IC50 1.0 Preclinical
CHEMBL4534333 9.0 IC50 1.0 Preclinical
CHEMBL4059534 8.7 IC50 1.995 Preclinical
CHEMBL4583880 8.7 IC50 1.995 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
3
5.5
7
6.0
9
6.5
18
7.0
12
7.5
13
8.0
7
8.5
8
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

12
Total Assays
76
Tested Compounds
2
Assay Types
Binding — 7 assays, 76 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 7 76 7.6
Functional — 5 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 5 1 4.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine